Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 15;20(1):346–356. doi: 10.3892/ol.2020.11536

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Jiang et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 7. — Synergistic antitumor effect of co-treatment with gemcitabine and sorafenib in non-small cell lung cancer xenograft model. (A) The images of tumor diameters of the different groups. (B) Tumor volume (*P<0.05 compared vs. gemcitabine group; **P<0.01 compared vs. gemcitabine group; ^##P<0.01 compared vs. sorafenib group). (C) Tumor weight (*P<0.05) and (D) body weight of the different groups (P>0.05). (E) Protein expression levels of N-cadherin, E-cadherin and Twist-1 in tumor tissues. (F-H) Quantitative analysis of (F) N-cadherin, (G) E-cadherin and (H) Twist-1. *P<0.05.